Daniel R Tessier

researcher

Daniel R Tessier is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-3702-9646

P69educated atUniversity of OttawaQ627969
P108employerUniversity of OttawaQ627969
P734family nameTessierQ21502352
TessierQ21502352
TessierQ21502352
P735given nameDanielQ14516546
DanielQ14516546
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q57305942A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q57056093Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Q36856357Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls
Q24633316Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q37342144Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation
Q37236216Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs).
Q36856343Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression
Q55380382Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q36956156GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
Q35925620Genetic predisposition to ductal carcinoma in situ of the breast
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q28388497Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q24622610Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Q27008356Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q37006170Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Q29417155Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Q36720814Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q36897003Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q64998464The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium.
Q37414133rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

Search more.